BioCentury
ARTICLE | Clinical News

BHR-100: Phase III ongoing

January 28, 2013 8:00 AM UTC

Besins' BHR Pharma LLC subsidiary said a DSMB recommended continuation of the double-blind, placebo-controlled, international Phase III SyNAPSe trial of BHR-100 based on safety data from 803 patients....